Tvardi Therapeutics

Ticker TVRD

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Sugar Land, Texas

Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases with significant unmet need.

Visit website

REPORT RATINGS

4.8 / 5.0 (177)

Tvardi Therapeutics reports have an aggregate usefulness score of 4.8 based on 177 reviews.

Tvardi Therapeutics

Most Recent Annual Report

MOST RECENT 2024 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Tvardi Therapeutics does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.